Danazol

cytochrome P450 family 2 subfamily J member 2 ; Homo sapiens







9 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33411110 Identifying the Dominant Contribution of Human Cytochrome P450 2J2 to the Metabolism of Rivaroxaban, an Oral Anticoagulant. 2022 Feb 1
2 33335233 Molecular determinant of substrate binding and specificity of cytochrome P450 2J2. 2020 Dec 17 1
3 29759885 Terfenadone is a strong inhibitor of CYP2J2 present in the human liver and intestinal microsomes. 2018 Jun 4
4 28237650 Inhibition and inactivation of human CYP2J2: Implications in cardiac pathophysiology and opportunities in cancer therapy. 2017 Jul 1 1
5 28698302 Heme Modification Contributes to the Mechanism-Based Inactivation of Human Cytochrome P450 2J2 by Two Terminal Acetylenic Compounds. 2017 Sep 2
6 26048912 Danazol Inhibits Cytochrome P450 2J2 Activity in a Substrate-independent Manner. 2015 Aug 8
7 24021950 Activity, inhibition, and induction of cytochrome P450 2J2 in adult human primary cardiomyocytes. 2013 Dec 1
8 22328583 Identifying a selective substrate and inhibitor pair for the evaluation of CYP2J2 activity. 2012 May 1
9 19923256 Identification of novel substrates for human cytochrome P450 2J2. 2010 Feb 1